SOX2 Promotes Brain Metastasis of Breast Cancer by Upregulating the Expression of FSCN1 and HBEGF

The prognosis of breast cancer brain metastasis (BCBM) is extremely poor due to its resistance to conventional therapy. Elucidation of the molecular mechanisms of BCBM could contribute to the development of new therapeutic targets. In this study, we isolated RNA samples from primary breast cancer or...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Weikai, Zheng, Shaoquan, Xie, Xinhua, Li, Xing, Zhang, Lijuan, Yang, Anli, Wang, Jian, Tang, Hailin, Xie, Xiaoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163054/
https://www.ncbi.nlm.nih.gov/pubmed/32322668
http://dx.doi.org/10.1016/j.omto.2020.03.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163054/
https://www.ncbi.nlm.nih.gov/pubmed/32322668
http://dx.doi.org/10.1016/j.omto.2020.03.001

Ejemplares similares